Please login to the form below
rights
This page shows the latest rights news and features for those working in and with pharma, biotech and healthcare.
Data integrity scuppers Fresenius deal with Akorn
It says it also intends to enforce its right under the “binding merger agreement”.
Latest news
-
Sanofi appoints ex-Roche Reed as new R&D head
Taking his place from 1 July will be John Reed (pictured right), who left his Basel-based role as Roche’s head of Pharma Research and Early Development (pRED) last month
-
New centre aims to Catapult UK into cell and gene therapy lead
Keith Thompson (pictured right), chief executive of the government-funded Cell and Gene Therapy Catapult, says the most obvious example of this was monoclonal antibodies, which the UK played a lead
-
Rigel and Ultragenyx claim approvals for rare drugs
Fostamatinib was being developed as a treatment for rheumatoid arthritis by AstraZeneca (AZ), but the big pharma company returned rights to the drug in 2013 after disappointing phase III trials.
-
Novartis negotiates ex-US rights to Spark gene therapy
Novartis negotiates ex-US rights to Spark gene therapy. Strikes $170m deal for Luxturna. ... The Swiss pharma group is paying $105m for ex-US rights to Luxturna (voretigene neparvovec-rzyl), which is currently filed for approval in the EU for the
-
Roche out-licenses lebrikizumab rights to Dermira
Roche out-licenses lebrikizumab rights to Dermira. Swiss drug maker stands to receive $80m upfront for the drug. ... Roche has opted to out-license the bulk of the rights to its IL-13 inhibitor lebrikizumab to dermatology company Dermira in a deal valued
More from news
Approximately 1 fully matching, plus 1,058 partially matching documents found.
Latest Intelligence
-
No incentive for a cure
And it is a revolution. that is happening right now; there are many such therapies in company pipelines, several of which are.
-
Brexit Means Brexit
There’s a coherence across the industry and a thread of rationality running right through the approach.
-
A new era of smart pharma
GDPR’s stipulation that patients who grant companies the use of their data can withdraw consent at any time and have it deleted (‘right to erasure’) contradicts regulations governing the integrity
-
Six degrees of participation
Everyone wins.”. Degree #5: Think broader than brand for the right to play. ... That’s powerful evidence. And it’s right at our fingertips in most therapy areas.
-
Health on instalment
No more searching the haystack for small molecule needles. Researchers can go right from identifying a genetic target to treating it, which should speed the discovery process considerably.
More from intelligence
Approximately 0 fully matching, plus 388 partially matching documents found.
Latest appointments
-
Publicis LifeBrands Team win UK young Cannes Lions competition
Shaheed Peera, executive creative director for Publicis LifeBrands, said: “We believe that we have the best talent in the industry and the right infrastructure to develop superstars and this is a
-
Neurocentrx appoints two members to the board
Neurocentrx, a UK-based pharmaceutical company, has appointed Nigel Brooksby (pictured right) as non-executive chairman.
-
Celgene boosts CAR-T stake again with Bluebird Bio deal
Now, it has exercised its option on the lead CAR-T from that programme - called bb2121 and currently in phase I trials - and will share development and promotional rights to the ... That deal gave it rights to Juno’s lead CAR-T candidate JCAR017
-
Ipsen bolsters leadership team
Ivana Magovcevic-Liebisch (pictured right) joins the pharmaceutical company as its executive vice president and chief business officer.
-
Leo Pharma appoints new senior vice president
We are serving more than 80 million patients worldwide, are launching several products and have an ambitious pipeline and Rhonda is the right person to continue to optimise our operations and
More from appointments
Approximately 0 fully matching, plus 229 partially matching documents found.
Latest from PMHub
-
Are you getting the balance right?
Are you getting the balance right? Research that helped shape the evolution of epgonline.org, the website for healthcare professionals.
-
Medical Translations: Why you need to get it right the first time
Medical Translations: Why you need to get it right the first time.
-
Deploy...
The last chapter of Accelerated Change, Deploy, ensures that we target the right audience, with the right content, using the most appropriate channels, to ultimately drive behaviour change.
-
Pitch Perfect?
work within budget.Tell them who they will be pitching to – helping them ensure the right team is available to deal with any questions that, say, I.T. ... REAL NEED. RESEARCH PITCH LIST. RIGHT INFORMATION. RESPECT THE PROCESS. RESPONSIVE TO
-
What is MaxDiff?
The scores are then indexed to 100 to aid interpretation. The result is a clear prioritisation of market preferences as can be seen in the figure on the right.MaxDiff has ... It’ s not for everyone however, but you’ ll see the benefits to a
More from PMHub
Approximately 0 fully matching, plus 417 partially matching documents found.
Featured jobs
-
Senior Programme Executive
-
Salary TBC
- Senior / Principal Regulatory Writer – Home Working - UK or US
-
HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS
- FREELANCE OPPORTUNITIES!!!!! Medical Education - Healthcare Adve...
-
EXCELLENT DAY RATES AVAILABLE
- Editor > Senior Editor – Medical Education – London
-
Very competitive with excellent benefits
-
Scientific Director
-
Great salary and bebefits
- FREELANCE Account Manager – Creative Healthcare Advertising – Lo...
-
SUPERB DAY RATES AVAILABLE
- Senior Account Manager / Account Director
-
Great salary and bebefits
- Principal Medical Writer, Medical Communications, Relocate to Ca...
-
Excellent Salary
- Account Manager – Med Comms – London
-
Salary TBC
-
Senior Medical Writer
-
Great salary and bebefits
- Senior Medical Writer, Medical Communications, Relocate to Cardi...
-
Excellent Salary
- Senior Account Manager – Med Comms – Kent
-
Salary TBC
- Head of Operations/ BUD, Healthcare PR, London – Excellent leade...
-
Excellent Package
-
Senior Medical Writer
-
Great salary and benefits
- Editorial Team Leader or Scientific Director
-
£50, 000 - £55, 000 benefits
-
Account Manager, Healthcare PR
-
£40, 000 – £42, 000 great benefits and bonuses
Subscribe to our email news alerts
- Ocrevus helps Roche stave off biosimilar threat
- GSK gets maintenance indication for Trelegy
- ABPI explores the future of medicines
- Morning brief: Roche raises outlook for 2018, ASCO abstracts revealed and more
- Ashfield will be exhibiting at ISMPP US
- Shire warms to Takeda’s latest offer, extending deadline
PMHub
Conversis
Conversis is a translation company specialising in translation and localisation for the Life Science and Pharmaceutical industry, with particular focus...
Latest intelligence
- Pharma’s isolated islands of innovation
- With service design and technology often failing the patient, why perspective on improving outcomes need to change...
- Uncertainty, austerity and Brexit
- What does it mean for the life science sector?...
- The Holy Grail of HCP Access
- This is the data you need to gain access....
Quick links
Infographics
